SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters.
Perturbations to mammalian SWI/SNF (mSWI/SNF or BAF) complexes contribute to more than 20% of human cancers, with driving roles first identified in malignant rhabdoid tumor, an aggressive pediatric cancer characterized by biallelic inactivation of the core BAF complex subunit SMARCB1 (BAF47). However, the mechanism by which this alteration contributes to tumorigenesis remains poorly understood. We find that BAF47 loss destabilizes BAF complexes on chromatin, absent significant changes in complex assembly or integrity. Rescue of BAF47 in BAF47-deficient sarcoma cell lines results in increased genome-wide BAF complex occupancy, facilitating widespread enhancer activation and opposition of Polycomb-mediated repression at bivalent promoters. We demonstrate differential regulation by two distinct mSWI/SNF assemblies, BAF and PBAF complexes, enhancers and promoters, respectively, suggesting that each complex has distinct functions that are perturbed upon BAF47 loss. Our results demonstrate collaborative mechanisms of mSWI/SNF-mediated gene activation, identifying functions that are co-opted or abated to drive human cancers and developmental disorders.
|Year of Publication||
|PubMed Central ID||
T32 GM007753 / GM / NIGMS NIH HHS / United States
R01 GM083084 / GM / NIGMS NIH HHS / United States
R01 HG005220 / HG / NHGRI NIH HHS / United States
T32 GM095450 / GM / NIGMS NIH HHS / United States
DP2 CA195762 / CA / NCI NIH HHS / United States